QUEST Study published

The QUEST study was published in the September/October 2008 edition of the Journal of Veterinary Internal Medicine. The global study is the largest of its kind undertaken in veterinary cardiology, with important implications for the treatment of heart disease.

Veterinarians wishing to find out more about the study and its results - please log in to the vet-only section of this site.

Dog owners wishing to find out more about the study - please visit www.questtrial.com

Choose Vetmedin first. Choose life.

Vetmedin is a breakthrough treatment for congestive heart failure in dogs.

Since its introduction in 2000, it has been shown to increase both quality of life and length of life in dogs suffering from congestive heart disease, above and beyond previous treatment regimes.

Understanding heart disease in dogs

Your dog’s heart is simply a muscular pump divided into four chambers – very similar in structure and function to your own. The most common causes of heart disease in dogs affect either the valves or muscle of the heart.

You and your vet

This website contains information for dog owners about the causes of heart failure in dogs, and about the treatment Vetmedin. The advice of a veterinary surgeon should always be sought if you suspect that your pet is suffering from congestive heart failure.

Vetmedin is a prescription medicine, and only available with a prescription from Veterinary Surgeons. Advice regarding the use of Vetmedin should be sought from your Veterinary Surgeon.

PROTECT study launched!

A major new study looking at Dobermans with pre-clinical dilated cardiomyopathy has been launched.

Log in

For the latest news, research, videos, practice resources and much more, please log in:

Surname: (or email if you have recently registered for the Norman competition)

Practice Postcode:

(PROTECT) Pimobendan Randomized Occult DCM Trial to Evaluate Clinical symptoms & Time to heart failure is a clinical trial investigating the benefit of administering Vetmedin to Dobermanns with pre-clinical DCM. Please log in to find out how you can become involved with the PROTECT study.